Iván Victoria

996 total citations
33 papers, 520 citations indexed

About

Iván Victoria is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Iván Victoria has authored 33 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Iván Victoria's work include Cancer Immunotherapy and Biomarkers (12 papers), Prostate Cancer Treatment and Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Iván Victoria is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Prostate Cancer Treatment and Research (6 papers) and Lung Cancer Treatments and Mutations (6 papers). Iván Victoria collaborates with scholars based in Spain, United States and United Kingdom. Iván Victoria's co-authors include Lydia Gaba, Aleix Prat, Ana Arance, Enriqueta Felip, Llúcia Alós, Núria Viñolas, S. Cedrés, Alex Martínez‐Martí, Cheng Fan and Tomás Pascual and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Iván Victoria

31 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iván Victoria Spain	11	367	193	155	151	91	33	520
Friedrich Graf Finckenstein United States	10	332 0.9×	175 0.9×	102 0.7×	139 0.9×	81 0.9×	17	481
Yutaka Shio Japan	12	250 0.7×	197 1.0×	114 0.7×	141 0.9×	122 1.3×	53	493
Angel Qin United States	12	343 0.9×	201 1.0×	94 0.6×	178 1.2×	122 1.3×	33	561
Julio A. Peguero United States	12	368 1.0×	241 1.2×	92 0.6×	133 0.9×	78 0.9×	49	517
Takumi Yamaura Japan	13	329 0.9×	215 1.1×	156 1.0×	200 1.3×	172 1.9×	38	603
Marta Batus United States	13	296 0.8×	243 1.3×	74 0.5×	178 1.2×	83 0.9×	60	569
Tijl Vermassen Belgium	14	285 0.8×	142 0.7×	157 1.0×	183 1.2×	59 0.6×	36	543
Karen Briscoe Australia	10	275 0.7×	212 1.1×	62 0.4×	127 0.8×	120 1.3×	21	557
Maria Bassanelli Italy	10	419 1.1×	326 1.7×	57 0.4×	99 0.7×	68 0.7×	23	547
Chau‐Wei Wong China	6	204 0.6×	233 1.2×	130 0.8×	334 2.2×	195 2.1×	6	582

Countries citing papers authored by Iván Victoria

Since Specialization

Citations

This map shows the geographic impact of Iván Victoria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Victoria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Victoria more than expected).

Fields of papers citing papers by Iván Victoria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Victoria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Victoria. The network helps show where Iván Victoria may publish in the future.

Co-authorship network of co-authors of Iván Victoria

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Victoria. A scholar is included among the top collaborators of Iván Victoria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Victoria. Iván Victoria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rha, Sun Young, Eduardo Castañón, Sanjeev Gill, et al.. (2025). Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort. Cancer. 131(16). e70015–e70015. 1 indexed citations

Langer, Corey J., Rachel Galot, Hans Prenen, et al.. (2024). Sotorasib plus panitumumab for pre-treated non-small cell lung cancer with KRASG12C mutation: A phase 1b study.. Journal of Clinical Oncology. 42(16_suppl). 8559–8559. 1 indexed citations

Li, Bob T., Jeffrey Clarke, Enriqueta Felip, et al.. (2024). Sotorasib plus carboplatin and pemetrexed in KRAS G12C advanced NSCLC: Updated analysis from the international CodeBreaK 101 trial.. Journal of Clinical Oncology. 42(16_suppl). 8512–8512. 8 indexed citations

Victoria, Iván, Laura Claverías, Mònica Magret, et al.. (2024). Impact of mechanical power on ICU mortality in ventilated critically ill patients: a retrospective study with continuous real-life data. European journal of medical research. 29(1). 491–491. 4 indexed citations

Clarke, Jeffrey, Enriqueta Felip, B.T. Li, et al.. (2023). MA06.05 CodeBreaK 101: Safety and Efficacy of Sotorasib with Carboplatin and Pemetrexed in KRAS G12C-Mutated Advanced NSCLC. Journal of Thoracic Oncology. 18(11). S118–S119. 12 indexed citations

Marín‐Aguilera, Mercedes, Natàlia Jiménez, Òscar Reig, et al.. (2021). Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes. Cancers. 13(19). 4960–4960. 11 indexed citations

Victoria, Iván, Pedro Jares, Núria Viñolas, et al.. (2021). Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice. Journal of Thoracic Disease. 13(3). 1658–1670. 5 indexed citations

Vidal, Laura, Iván Victoria, Lydia Gaba, et al.. (2021). A first-in-human phase I/Ib dose-escalation clinical trial of the autophagy inducer ABTL0812 in patients with advanced solid tumours. European Journal of Cancer. 146. 87–94. 18 indexed citations

Martínez-Vila, Clara, Elia Seguí, Joan Padrosa, et al.. (2021). Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma. Journal of Immunotherapy. 44(5). 204–207. 3 indexed citations

10.

Marín‐Aguilera, Mercedes, Natàlia Jiménez, Òscar Reig, et al.. (2020). Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer. Cells. 9(1). 203–203. 18 indexed citations

11.

Jiménez, Natàlia, Òscar Reig, Maria Milà‐Guasch, et al.. (2020). Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer. Frontiers in Oncology. 10. 594023–594023. 10 indexed citations

12.

Jiménez, Natàlia, Òscar Reig, Iván Victoria, et al.. (2019). Cell plasticity associated to taxane-resistance in preclinical cell models and in circulating tumor cells from metastatic castration-resistant prostate cancer patients.. Journal of Clinical Oncology. 37(7_suppl). 238–238. 2 indexed citations

13.

Buxó, Elvira, Aaron E. Sosa, Òscar Reig, et al.. (2018). Intravenous 5-Fluorouracil in Patients With Advanced Squamous Cell Carcinoma: A Retrospective Study. Annals of Otology Rhinology & Laryngology. 127(7). 456–462. 2 indexed citations

14.

Prat, Aleix, Alejandro Navarro, Laia Paré, et al.. (2017). Immune-Related Gene Expression Profiling After PD-1 Blockade in Non–Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma. Cancer Research. 77(13). 3540–3550. 277 indexed citations

15.

Sepúlveda, María, Eugenia Martínez‐Hernández, Lydia Gaba, et al.. (2017). Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma. Muscle & Nerve. 56(6). E162–E167. 19 indexed citations

16.

Puig, Susana, Cristina Carrera, Ana Arance, et al.. (2016). Development of Cutaneous Toxicities During Selective Anti-BRAF Therapies: Preventive Role of Combination with MEK Inhibitors. Acta Dermato Venereologica. 97(2). 258–260. 6 indexed citations

17.

Gaba, Lydia, Iván Victoria, Aranzazu Fernández-Martínez, et al.. (2016). Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis. ESMO Open. 1(1). e000032–e000032. 6 indexed citations

18.

Fernández-Martínez, Aranzazu, Lydia Gaba, Iván Victoria, et al.. (2016). Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma. Clinical & Translational Oncology. 19(1). 119–124. 24 indexed citations

19.

Alfón, José, Laura Vidal, Lydia Gaba, et al.. (2016). Determination of recommended phase II dose of ABTL0812, a novel regulator of Akt/mTOR axis, by pharmacokinetic-pharmacodynamic modelling. Annals of Oncology. 27. vi120–vi120. 1 indexed citations

20.

Gaba, Lydia, Iván Victoria, Estela Pineda, et al.. (2015). Changes in blood eosinophilia during anti-PD1 therapy as a predictor of long term disease control in metastatic melanoma.. Journal of Clinical Oncology. 33(15_suppl). 9069–9069. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact